Results 261 to 270 of about 572,077 (339)

High‐risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies

, 2011
Deborah Tamura, Melissa A. Merideth, John J. DiGiovanna, Xiaolong Zhou, Margaret A. Tucker, Alisa M. Goldstein, Brian P. Brooks, Sikandar G. Khan, Kyu‐Seon Oh, Takahiro Ueda, Jennifer Boyle, Roxana Moslehi, Kenneth H. Kraemer   +12 more
openalex   +2 more sources

“You're this person who's providing light”: Embodied responses to information loss and transition within LGBTQIA+ communities

Journal of the Association for Information Science and Technology, EarlyView.
Abstract This paper reports on findings from 15 semi‐structured interviews with LGBTQIA+ individuals within the United States who have experienced the loss of one or more LGBTQIA+ information spaces. The paper specifically focuses on how such losses occurred and the information transitions experienced by the participants in response to this loss ...
Travis L. Wagner, Vanessa L. Kitzie
wiley   +1 more source

Impact of Pre-Pregnancy Body Mass Index and Gestational Weight Gain on Pregnancy Complications and Outcomes. [PDF]

Int J Gen Med
Long J, Chu Z, Xiao Y, Chen C, Zhang J, Yi X, Liu F, Hu G.   +7 more
europepmc   +1 more source

Clinical science and care incorporating the development of a European Platform for Clinical Research in Diabetes (EPCRD) [PDF]

, 2010
Danne, T., Diamant, M., Hood, G., Kautzky-Willer, A., Kerr, David, Mitrakou, A., Nilsson, P.A., Nolan, J. J, Pacini, G.   +8 more
core  

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Specialized pro-resolving mediators: key regulators in placental function and pregnancy complications. [PDF]

J Mol Med (Berl)
Sousa LG, Correia-da-Silva G, Teixeira N, Fonseca BM.   +3 more
europepmc   +1 more source

Effect of developmental changes on pharmacokinetics of drugs used in the treatment of infant acute lymphoblastic leukaemia—A comprehensive review

British Journal of Clinical Pharmacology, EarlyView.
While the event‐free survival (EFS) of children treated for acute lymphoblastic leukaemia (ALL) has improved greatly in the last decades, the EFS for patients diagnosed with ALL before the age of one is still under 50%. This outcome further decreases when infants have a rearrangement in the gene encoding histone‐lysine N‐methyltransferase 2A (KMT2A ...
Tirsa de Kluis, Leiah J. Brigitha, Lidwien M. Hanff, Alwin D. R. Huitema, Inge M. van der Sluis, Meta H. M. Diekstra   +5 more
wiley   +1 more source

The Association Between Pregnancy Complications and Long-term Maternal Cardiometabolic Health in the MIREC Cohort Study.

J Clin Endocrinol Metab
Fisher M, Smith G, Potter BK, Arbuckle TE, Little J, Weiler H, Morisset AS, Lanphear B, Braun JM, Kumarathasan P, Walker M, Borghese MM, Ashley-Martin J, Shutt R, Dodds L, Bruin JE, Palaniyandi J, Helewa M, Taback S, Massarelli I, Palmert MR, Krzeczkowski J, Fraser WD.   +22 more
europepmc   +1 more source

The Effect of Maternal Stress on 11beta-Hydroxysteroid Dehydrogenase Activity During Pregnancy: Evidence for Potential Pregnancy Complications and Consequences on Fetal Development and Metabolism. [PDF]

Int J Mol Sci
Pavli P, Mastorakos G, Eleftheriades M, Valsamakis G.   +3 more
europepmc   +1 more source

A real‐world data‐driven approach to optimizing enoxaparin dosing in burn patients

British Journal of Clinical Pharmacology, EarlyView.
Aim Enoxaparin dosing in burn patients is challenging due to physiological changes affecting absorption, distribution and clearance. The objectives of this study are to develop a population pharmacokinetic (PK) model for enoxaparin in burn patients, evaluate target attainment with current equation‐based (EQ) dosing and propose an optimized dosing ...
Babajide Shenkoya, Venkata Yellepeddi, Ann Marie B. Prazak, Mathangi Gopalakrishnan   +3 more
wiley   +1 more source